|
Title
|
|
|
|
Phase
|
|
|
|
Protocol IDs
|
|
|
|
Total Thyroidectomy With Harmonic Scalpel®
|
|
|
|
Phase IV
|
|
|
|
CP005
NCT00385983
|
|
|
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
|
|
|
|
Phase IV
|
|
|
|
Dathyrca 1
EudrCT 2007-002713-39, HB-2007-043, Data register 2007-41-120, NCT00604318
|
|
|
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
|
|
|
|
Phase III, Phase II
|
|
|
|
06-2247
NCT00442533
|
|
|
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
OXC4T4-302
NCT00507429
|
|
|
Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid Cancer
|
|
|
|
Phase III
|
|
|
|
CRUK-HILO-BRD/05/83
ISRCTN56078540, EU-20665, CTA-20363/0217/001/0001, EUDRACT-2005-003687-37, NCT00415233
|
|
|
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
|
|
|
|
Phase III
|
|
|
|
Estimabl
CSET 1216, NCT00435851
|
|
|
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
|
|
|
|
Phase III
|
|
|
|
XL184-301
NCT00704730
|
|
|
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
CTCT 06-11
NCT00493883
|
|
|
Vandetanib in Treating Young Patients With Medullary Thyroid Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
NCI-07-C-0189
07-C-0189, NCT00514046
|
|
|
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPAR? Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
|
|
|
|
Phase II, Phase I
|
|
|
|
CS7017-A-U103
NCT00603941
|
|